Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

Add To Watchlist

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > PP

View:

Post by Cotitwo on Sep 16, 2017 7:11pm

PP

I'm afraid the stock price will be kept lower for a while longer. Once the financing closes we should reach bottom and then start to go up with gynecoligical study results and the start of Head and Neck trials begin

149

Comment

Comment by DIYGuy on Sep 20, 2017 7:48am

https://finance.yahoo.com/news/critical-outcome-technologies-closes-1-110000412.html?.tsrc=applewf 1st tranche with another round expected to close on a few weeks. So, we have a little money again. Now we need the announcement of the start of the HNSCC trial and then we wait...hopefully it goes smoothly. Don't need anymore hurricanes in a Texas.

Comment

Cotinga Pharmaceuticals Inc